Ava Investors

Blaize, Inc., founded in 2010 and headquartered in El Dorado Hills, California, specializes in edge AI processing solutions through its proprietary hardware architecture and low-code/no-code software platform. The company targets various industries, including automotive, retail, security, industrial automation, and healthcare, providing efficient solutions that address the challenges of edge AI processing, such as low latency and high thermal and power efficiency. Blaize's innovative approach overcomes limitations of traditional AI solutions, which are often optimized for data centers rather than edge environments. With a workforce of over 200 employees, the company has established teams in California, North Carolina, and international subsidiaries in India and the UK. Blaize has successfully raised over $200 million from a mix of strategic and financial investors, reinforcing its position as a leader in the AI-enabled edge computing market.

Multiwave Imaging is a leading company specializing in the design of metamaterial antennas for Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) systems. Established in March 2015 and headquartered in Geneva, Switzerland, with a research and development facility in France, Multiwave focuses on developing innovative medical imaging devices. The company aims to enhance imaging quality in MRI, ultimately aiding in the treatment of neurological conditions. In addition to its core imaging technologies, Multiwave employs advanced quantitative portfolio analysis and sensor technologies to support retailers in their purchasing strategies, thereby maximizing profits. Through these initiatives, Multiwave Imaging seeks to advance the field of medical imaging while addressing critical healthcare needs.

Rejuveron Life Sciences AG is a biotechnology company based in Zug, Switzerland, founded in 2019. The company focuses on developing and investing in innovative drugs and technologies aimed at promoting healthy aging and extending lifespan. As a fully integrated platform, Rejuveron combines its investment strategies with a commitment to advancing therapies that address age-related conditions, leveraging both scientific research and entrepreneurial initiatives in the life sciences sector.